Intact Vascular increases Series B to $46M at $78M valuation
January 05, 2017
Surgical Devices | Wayne, PA | Series B
Medical device company Intact Vascular develops products for minimally invasive peripheral vascular procedures; the company is currently sponsoring three international clinical trials. Intact's Series B initially closed on $38.9 million in 2015, and the company raised a $4.7 million round in 2013 that generated a valuation of $30.4 million.